|
Sildenafil Citrate
|
|
Sildenafil Citrate
Synonyms: sildenafil citrate; steroid powder; hormone powders; raw powder; pharmaceutical intermediate; pharmaceutical raw materials
CAS#: 139755-83-2
Assay: 98%-101%
Appearan
|
| |
Sildenafil Mesylate 139755-83-2
|
|
Sildenafil Mesylate 139755-83-2CAS No.:139755-83-2Molecular Formula: C22H30B6O4S. CH3SO3H Molecular Weight: 570 Appearance: white to almost white crystalline powder, odorless, a little acerbity, solub
|
| |
Sodium Alginate 9005-38-3
|
|
Sodium Alginate 9005-38-3CAS registry number:9005-38-3MF:C6H7NaO6 Specifications Sodium Alginate is odorless,white or light yellow powder.It's used in textile printing and dyeing auxiliary agent e
|
|
|
Sodium Aluminium Silicate 1344-00-9
|
|
Sodium Aluminium Silicate 1344-00-9MF: AlNaO6Si2 CAS No.: 1344-00-9Purity: 82%EINECS No.:215-684-8 Appearance: White amorphous subdivision or powder, odorless and tastelessApplication: Can be us
|
| |
Sodium L-aspartate 3792-50-5
|
|
Sodium L-aspartate 3792-50-5Molecular formula: C4H6NO4Na.H2O Molecular structure: Molecular weight:155.08CAS No.:3792-50-5【Descr
|
| |
Sodium L-lactate
|
|
Sodium L-lactateMolecular formula: C3H5NAO3 Molecular weight: 112.06 CAS number: 867-56-1 EINECS: 212-762-3Appearance:slightly yellowish transparent liquid Usage: It is a kind of natural food add
|
|
|
Sodium Levothyroxine 25416-65-3
|
|
Sodium Levothyroxine 25416-65-3 Synonyms: L-Thyroxine sodium salt hydrateCAS: 25416-65-3 EINECS: 200-221-4 Assay: 99% min. USP30 Packing: 1 kg/foil bag or tin.MF: C15H10I4NNaO4 MW: 798.85 Character:
|
| |
Sodium Polyacrylate 9003-04-7
|
|
Sodium Polyacrylate 9003-04-7CAS No.: 9003-04-7MF: [C3H3O2Na]n Appearance: white powder without orderOther name: NaPAA;PAA(S) Application: can be used as thickener. Flocculants may accelerate the se
|
| |
Soluble Soybean Protein Peptides
|
|
Soluble Soybean Protein PeptidesCAS No.: 9010-10-0 EINECS No.:232-720-8 MF: C12H12N2O3Soy Peptide was derived from refined isolated soy protein by enzyme method, As a new functional nutritional addi
|
|